The agreement allows the company to refinance its current debt while gaining additional working capital capacity. The $15 million term loan is fully funded at closing, with an interest-only period extending through June 30, 2029, and a final maturity date in June 2031. The separate $30 million line of credit matures in June 2029, with a potential $5 million accordion feature available pending specific conditions.
Shoulder Innovations Secures $50 Million Credit Facility
Grand Rapids-based medical technology firm Shoulder Innovations has finalized a new $50 million credit facility with Stifel Venture Banking, replacing its existing debt structure with more favorable terms. The deal includes a $15 million term loan and a $30 million undrawn line of credit to support ongoing expansion.
Chief Financial Officer Jeff Points stated that the refinancing strengthens the company's financial foundation and improves the economics of its debt profile. The new arrangement avoids issuing warrants and does not increase the firm's total indebtedness at the time of closing. Shoulder Innovations, which focuses on advanced implant systems for shoulder arthroplasty, plans to file further details regarding the transaction in a Form 8-K report with the U.S. Securities and Exchange Commission.
:max_bytes(150000):strip_icc()/244375memphis-dry-rubYoly4x3-499808b04e164d0cb816d9925733c9ad.jpg)
Comments (0)
No comments yet. Be the first!